Group Post |
UK to allow emergency use of any effective COVID-19 vaccine |
mike kraft |
Group Post |
Large U.S. covid-19 vaccine trials are halfway enrolled, but lag on participant diversity |
mike kraft |
Group Post |
Doctors find possible case of Covid-19 reinfection in US |
mike kraft |
Group Post |
ANALYSIS/FACTCHECK: G.O.P. Convention Created an Alternative America Beyond Covid-19 |
mike kraft |
Group Post |
Coronavirus cases in some European countries are rising again, but with fewer deaths. For now. |
mike kraft |
Group Post |
Hundreds protest against exams in India as virus cases hit new peak |
mike kraft |
Group Post |
COVID-19 treatment without research to back it up |
mike kraft |
Group Post |
U.S. coronavirus cases approach 6 million as Midwest, schools face outbreaks |
mike kraft |
Group Post |
Looking to Reopen, Colleges Become Labs for Coronavirus Tests and Tracking Apps |
mike kraft |
Group Post |
Mutated coronavirus strain found in Indonesia as cases jump |
mike kraft |
Group Post |
EU offers 400 million euros to WHO-led COVID-19 vaccine initiative |
mike kraft |
Group Post |
Scientists see downsides to top COVID-10 vaccines from Russia, China |
mike kraft |
Group Post |
FDA head says agency could consider authorization for Covid-19 vaccine before Phase 3 trials are complete, Financial Times reports |
mike kraft |
Group Post |
ANALYSIS: Inside Trump’s pressure campaign on federal scientists over a covid-19 treatment |
mike kraft |
Group Post |
IN DEPTH: U.S. Will Revive Global Virus-Hunting Effort Ended Last Year |
mike kraft |
Group Post |
U.S. Coronavirus Rates Are Rising Fast Among Children |
mike kraft |
Group Post |
Patchwork approach to contact tracing hampers national recovery |
mike kraft |
Group Post |
Cntact Tracing: How Germany and Israel respond in different ways |
mike kraft |
Group Post |
Pandemic brings hard times for farmers, worsening hunger |
mike kraft |
Group Post |
AstraZeneca's coronavirus vaccine becomes third to begin Phase three trials in the United States |
mike kraft |
Group Post |
New Trump pandemic adviser pushes controversial ‘herd immunity’ strategy, worrying public health officials |
mike kraft |
Group Post |
What is herd immunity, and why are Trump officials pursuing an idea WHO calls ‘dangerous’? |
mike kraft |
Group Post |
Russia's virus cases exceed 1 million; 4th highest globally |
mike kraft |
Group Post |
Large antibody study offers hope for virus vaccine efforts |
mike kraft |
Group Post |
US says it won't join global effort to find COVID-19 vaccine |
mike kraft |
Recent Comments